Clinical Trial Update: A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study to compare PK and PD of GZR102, GZR4, and GZR18 injections given separately in overweight Chinese adults with Type 2 diabetes mellitus. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GZR102 Injection
• GZR18 Injection
• GZR4 Injection (GZR4)

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Type 2 Diabetes | Phase 1 | Status: NOT_YET_RECRUITING